Hong Kong authorities have asked Japan to remove restrictions on direct flights from the city following the mainland’s explosion of coronavirus cases.
Officials from Hong Kong's transportation department said it was "greatly disappointed by Japan’s hasty decision during the peak tourist season".
The department said it had contacted the Japanese consulate in Hong Kong to request a reversal of the decision, which takes effect from Friday.
The affected airlines have been told they can still fly empty planes to the restricted airports to pick up any stranded passengers in the coming days.
They include restricting direct flights from Hong Kong to four airports -- Tokyo's Narita and Haneda, Kansai in Osaka, and Nagoya's Chubu.
Japan became among the first countries to impose China-specific travel restrictions as infections surged across the mainland this week, following the dismantling of Beijing's zero-COVID strategy.


Debate over H-1B visas shines spotlight on US tech worker shortages
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Canada’s local food system faces major roadblocks without urgent policy changes
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Why a ‘rip-off’ degree might be worth the money after all – research study
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Instagram Outage Disrupts Thousands of U.S. Users
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio 



